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ABSTRACT
Histone mRNAs are the only eukaryotic cellular mRNAs that are not polyadenylated. Synthesis of mature histone mRNA
requires only a single processing reaction: an endonucleolytic cleavage between a conserved stem–loop and a purine-rich
downstream element to form the 39 end. The stem–loop binding protein (SLBP) is required for processing, and following
processing, histone mRNA is transported to the cytoplasm, where SLBP participates in translation of the histone mRNA and is
also involved in regulation of histone mRNA degradation. Here we present an analysis of histone mRNA metabolism in cells with
highly reduced levels of SLBP using RNA interference. Knocking down SLBP in U2OS cells results in a reduction in the rate of
cell growth and an accumulation of cells in S-phase. Surprisingly, there is only a modest (twofold) decrease in histone mRNA
levels. Much of histone mRNA in the SLBP knockdown cells is properly processed but is retained in the nucleus. The processed
histone mRNA in SLBP knockdown cells is not rapidly degraded when DNA replication is inhibited. These results suggest a
previously undescribed role for SLBP in histone mRNA export.
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INTRODUCTION
The replication-dependent histone mRNAs are the only
eukaryotic cellular mRNAs that are not polyadenylated,
ending instead in a conserved stem–loop (SL) (Marzluff
2005). These mRNAs lack introns and undergo a single
processing reaction cleaving the nascent pre-mRNA from
the DNA template and producing the mature mRNA. The
cleavage reaction requires the stem–loop 59 of the cleavage
site and a purine-rich region, the histone downstream
element (HDE), located z10 nucleotides (nt) 39 of the
cleavage site. The HDE base pairs with the U7 small nuclear
RNA, which is a component of the U7 snRNP (Mowry and
Steitz 1987). The stem–loop binding protein (SLBP) binds
to the SL and helps stabilize the interaction of U7 snRNP
with the pre-mRNA. Several lines of evidence support this
model. Pull-down of biotinylated histone pre-mRNA from
nuclear extracts results in the concomitant pull-down of
the U7 snRNA (Dominski et al. 1999, 2001), which is
enhanced by SLBP. In vitro processing of histone pre-
mRNA is absolutely dependent on SLBP if the HDE does
not interact strongly with U7 snRNA (Dominski et al.
1999). The factor ZFP100 interacts with both the SLBP/SL
complex (Dominski et al. 2002) as well as the U7 snRNP
specific Sm-like protein Lsm11 (Azzouz et al. 2005; Wagner
et al. 2006) and is limiting for histone pre-RNA processing
in vivo (Wagner and Marzluff 2006). Mutations in the
stem–loop that abolish binding of SLBP result in no
expression of processed histone mRNA in vivo (Pandey
et al. 1994).
The requirement of SLBP for in vitro processing of
histone pre-mRNA in nuclear extracts from mammalian
cells on many substrates is not absolute. Extracts depleted of
SLBP are incapable of processing the H1t histone pre-mRNA
but are competent to process the H2A-614 histone pre-
mRNA (Dominski et al. 1999). The difference between these
two substrates is that U7 snRNP base pairs more extensively
with the HDE of H2A-614 than with the H1t HDE.
Once the U7 snRNP is bound to the HDE, a cleavage
factor is recruited containing at least CPSF73 (Dominski
et al. 2005) and Symplekin (Kolev and Steitz 2005). CPSF73
is likely the endonuclease that cleaves the histone pre-
mRNA from the DNA template (Dominski et al. 2005). The
other components of the cleavage factor and the mechanism
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of recruitment of the cleavage factor to the U7 snRNP/
SLBP/SL complex have not been elucidated.
The molecular events that take place following process-
ing in the nucleus and prior to the translation of histone
mRNA in the cytoplasm are less well understood. What is
clear is that the histone mRNA is rapidly exported (within 5
min) (Schochetman and Perry 1972), and export in
Drosophila S2 cells (Erkmann et al. 2005a) and Xenopus
oocytes (Huang and Steitz 2001) is dependent on TAP.
SLBP is present in the cytoplasm only when histone mRNA
is present (Erkmann et al. 2005b), where it is specifically
associated with the histone mRNP (Whitfield et al. 2004;
Townley-Tilson et al. 2006). In Xenopus oocytes, expression
of SLBP stimulates the translation of reporter genes ending
in a stem–loop (Sanchez and Marzluff 2002). Recently it
has been reported that SLBP interacts with a novel protein,
SLIP1, which also interacts with EIF4G and plays a role in
translation of histone mRNA (Cakmakci et al. 2008). These
data are all consistent with a role of SLBP in the translation
of histone mRNA.
In late S phase or when DNA replication is inhibited,
histone mRNAs are rapidly degraded. The rapid decay of
existing histone mRNA likely requires SLBP. Upf1 binds to
SLBP at the 39 end of histone mRNA immediately after
inhibition of DNA replication and is required for histone
mRNA degradation (Kaygun and Marzluff 2005a). Recently,
we reported that an oligo(U) tail is added to the 39 end of
histone mRNA shortly after inhibiting DNA replication
(Mullen and Marzluff 2008). This oligo(U) tail provides a
binding site for Lsm1-7, which binds to the oligouridylated
histone mRNA together with SLBP. The Lsm1-7 complex
likely recruits the enzymes that degrade histone mRNA
as it does for poly(A) mRNAs (Parker and Song 2004).
SLBP is a cell-cycle regulated protein that accumulates just
before entry into S-phase to activate histone pre-mRNA
processing, and SLBP is degraded at the end of S-phase.
Stabilization of SLBP by mutating the phosphorylation
sites required for degradation does not affect degrada-
tion of histone mRNA (Zheng et al. 2003), indicating that
SLBP degradation is not required for histone mRNA
degradation.
In order to understand the critical roles of SLBP in cells,
we knocked down SLBP using RNA interference in U2OS
cells. Previously, we, and others, had shown that reduction
of SLBP levels results in a reduction in the rate of cell
growth and an accumulation of cells in S-phase (Zhao et al.
2004; Wagner et al. 2005). However, a thorough molecular
analysis of the effect of SLBP knockdown on histone mRNA
metabolism has not been reported. Here we show that the
major lesion in histone mRNA metabolism as a result of
knocking down SLBP is not in histone pre-mRNA process-
ing, but in the export of histone mRNA to the cytoplasm.
Properly processed histone mRNA accumulates in the
nucleus. Together, these results implicate SLBP as having
a critical histone mRNA export function in mammalian
cells, as well as its known roles in histone pre-mRNA
processing, histone mRNA translation, and regulation of
histone mRNA half-life.
RESULTS
SLBP is required for cell growth
We determined the effect of knocking down SLBP in U2OS
cells using a double-stranded siRNA that specifically targets
SLBP mRNA. Previously we have shown that knockdown
of SLBP with this siRNA results in an increase in S-phase
cells, and that we can rescue this phenotype by expressing
an RNAi-resistant SLBP. Moreover, Muller and colleagues
(Zhao et al. 2004) demonstrated that reduced expression of
SLBP also resulted in a defect in S-phase progression and a
reduced expression of histone mRNAs. Both studies dem-
onstrated S-phase defects but did not elucidate the specific
molecular defects underlying this phenotype.
Since we initially observed variable results, which were
dependent on the extent of SLBP knockdown, we opti-
mized the knockdown, both for extent and duration,
allowing us to assay for histone mRNA metabolic defects
while still maintaining efficient SLBP knockdown. We used
Western blotting to monitor SLBP protein levels over
various times throughout the RNAi transfection (Fig.
1A). Reproducible phenotypes required a knockdown of
SLBP >95%, as determined by comparing Western blot
intensities from SLBP knockdown cells and a series of
dilutions of the control lysates (Fig. 1B, bottom panel).
U2OS cells were plated in 24 well dishes and, the following
day, transfected with either control (C2) or SLBP (S2)
siRNA. We determined the levels of SLBP every 24 h. The
day after the first transfection (24 h) (Fig. 1A, lanes 2,3),
SLBP protein levels were slightly lower in C2 treated cells
than in untransfected cells (Fig. 1A, lane 2). This decrease is
likely due to the high cell density used to achieve effective
transfection, resulting in a reduction in the number of S-
phase cells that contain SLBP. After 24 h, we split the cells
out of the 24 well dishes and replated them into 6-well
tissue culture dishes. Twenty-four hours later (48 h after
first siRNA treatment), we transfected the second dose of
siRNA and monitored SLBP levels for the next 4 d. Between
72 and 120 h following the initial hit of siRNA, SLBP
protein levels were down-regulated >95%, and experiments
assaying histone mRNA metabolism were done during this
time. Note that there is clearly some residual SLBP present
in the cells at all times. By 144 h, SLBP levels had started to
recover (data not shown).
As previously shown, knockdown of SLBP to this level
resulted in an increase in the number of cells in S-phase
(Wagner et al. 2005). We determined the rate of growth of
the cells by measuring cell number at the various time
points in Fig. 1A. The SLBP knockdown cells grew more
slowly, resulting in 30%–40% fewer cells after 5 d of
Sullivan et al.
460 RNA, Vol. 15, No. 3
growth. All the cells were viable, and there was no evidence
of apoptosis, suggesting that the cells were growing at a
slower rate.
Reducing the levels of SLBP decreases the rate
of DNA synthesis and activates an S-phase cell
cycle checkpoint
To confirm that the SLBP knockdown cells were accumu-
lating in S-phase, we analyzed these cells by flow cytometry.
We also asked whether these cells were still synthesizing
DNA by pulsing the C2 or S2 siRNA treated U2OS cells
with bromodeoxyuridine (BrdU), a thymidine analog, for
30 min followed by analysis of incorporation by FACS,
using a FITC coupled anti-BrdU antibody. As a control,
we treated cells transfected with C2 (control) siRNA with
5 mM hydroxyurea (HU) for 1 h to abolish BrdU incorpo-
ration. The DNA content was measured by propidium
iodide staining, and the incorporation of BrdU was
measured by FACS. As demonstrated previously, the SLBP
FIGURE 1. SLBP knockdown cells are viable but grow at a slower rate as a result of various S-phase defects. (A) Growth curve (total cell number)
of control (C2) and SLBP (S2) RNAi populations. Lysates from the time points shown in the graph were probed for levels of SLBP by Western
blotting; (*) cross-reacting band. (B) SLBP knockdown results in S-phase accumulation and a reduced rate of DNA replication. C2 and S2 treated
(72 h) U2OS cells were pulsed for 1 h with 10 mM bromodeoxyuridine (BrdU) and harvested and analyzed by FACS for DNA content and DNA
synthesis. Hydroxyurea (HU; 5 mM) was added to a parallel culture of C2 cells 1 h prior to the addition of BrdU. Cells were fixed and BrdU
incorporation detected with an anti-BrdU antibody conjugated to FITC and for DNA content with propidium iodide. Cells were analyzed using a
FACScan device and Summit software for DNA content and intensity of BrdU incorporation. The levels of SLBP in a typical experiment are
shown below the graph. They were determined by Western blotting compared to a dilution series of a control extract (1:2 to 1:20). (C) The cell
cycle distribution (G1, early and late S phase, and G2/M) was quantified from the data in B ([gray bars] C2; [black bars] S2) from three
independent experiments. Quantities are expressed as a percentage of the C2 control cells. (D) Parallel cultures from B were fixed and stained with
an antibody to the mitotic marker phospho-histone H3, and the antibody was detected with a secondary antibody conjugated to FITC. Cells were
analyzed similarly as in B, and the percentage of cells with fluorescent signal in the G2 population was quantified. The number of phospho-histone
positive cells is expressed as a percentage of the C2 control cells. (E) SLBP knockdown results in the activation of a Chk1-dependent cell cycle
checkpoint. Protein lysates from SLBP knockdown cells were analyzed by Western blotting for SLBP, total Chk1 protein, and two phosphorylation
sites (serines 317 and 345) using phospho-specific Chk1antibodies. Cells treated with HU for 1 h were used a positive control for Chk1 activation.
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knockdown cells accumulated in S-phase of the cell cycle
(Fig. 1B, top panel). From the FACS analysis of BrdU
incorporation (Fig. 1B, center panel), it is clear that SLBP
knockdown cells are still synthesizing DNA (all the S-phase
cells incorporated BrdU), but they were synthesizing DNA
at about one-half of the rate as control cells, as judged by
the intensity of BrdU staining. In the control RNAi (C2)
cells (Fig. 1B, left panel), there is efficient incorporation of
BrdU as detected by a FITC-conjugated antibody to BrdU.
The characteristic arc (Hoek and Stillman 2003) of BrdU
incorporation is present in the control cells, showing the
high rate of incorporation in early S-phase, and only a
small percentage of cells under the arc not incorporating
BrdU. In contrast, the SLBP knockdown cells (S2) have a
markedly lower BrdU-FITC signal overall and lack the
characteristic arc observed in control cells (Fig. 1B, center
panel), suggesting that their rate of DNA synthesis is reduced.
C2-treated cells treated with HU for 1 h prior to addition of
BrdU did not incorporate BrdU (Fig. 1B, right panel).
We also used the BrdU FACS analysis to quantify the cell
cycle phase distribution at a higher resolution in the SLBP
knockdown cells compared to the C2 control (Fig. 1C). We
quantified the G1- and G2-phases as the populations at 2N
and 4N, respectively, that did not incorporate BrdU. We
separated S-phase into two phases, early and late, by
quantifying the two populations that were between 2N
and 3N, and 3N and 4N. It is clear from this representation
(Fig. 1C) that S2-treated cells accumulate both in the early
part of S-phase and also in late S-phase, indicating that the
cells have difficulty completing S-phase. The number of
cells in G2-phase was reduced by 40%, consistent with cells
progressing through S-phase more slowly but through G2/M
and G1 normally.
We also determined the mitotic rate in the SLBP
knockdown cells using an antibody to phosphorylated
histone H3 (serine 10) as a mitotic marker. Positive cells
were measured by FACS and were quantified as a percent-
age of the control (Fig. 1D). It is clear from the mitotic
index data that SLBP knockdown cells are going through
mitosis at approximately half the rate of C2 control cells,
consistent with the finding that G2 cells are reduced by
40%. This is in agreement with the interpretation that there
is not a block in progression through G2, but rather a block
in completing S-phase (and, hence, in entering G2).
We next determined whether the reduced rate of DNA
replication resulted in activation of the S-phase checkpoint,
a consequence of defective chromosome replication, dam-
aged DNA, or environmental stress (Sancar et al. 2004). It
has been shown previously that overexpression of a domi-
nant-negative chromatin assembly factor 1 (CAF1) or
RNAi to CAF1 produces a similar DNA replication phe-
notype as knocking down SLBP (Hoek and Stillman 2003;
Ye et al. 2003). We hypothesized that reducing the levels of
SLBP might result in impaired histone protein biosynthesis
and hence mimic the defective chromatin assembly phe-
notype since the chromatin assembly machinery would not
have enough histone proteins to properly assemble chro-
matin.
We assessed the phosphorylation of Chk1, a kinase that
is activated by the ATR kinase when DNA replication stress
is sensed in S-phase cells. As a control, we again used C2
control cells treated with HU for 1 h since HU treatment is
known to activate the DNA replication checkpoint (Sancar
et al. 2004). There was increased Chk1 phosphorylation on
both serine 345 (S345) and serine 317 (S317) in response to
SLBP knockdown (Fig. 1E). The levels of Chk1 phosphor-
ylation on each of these serine residues were higher than
that in control cells but less than that in the HU-treated C2
siRNA population. This result supports the notion that
reducing the levels of SLBP results in a partial inhibition of
DNA replication phenotype that is directly sensed by the
S-phase checkpoint sensor and effector molecules.
Processed histone mRNA levels are only reduced
50% in SLBP knockdown cells
Since SLBP is involved in histone pre-mRNA processing,
we determined the levels of histone mRNA, both by
Northern blotting and by S1 nuclease mapping to assess
whether the 39-end was formed properly. We used North-
ern blots to determine histone mRNA levels for all five
histone proteins, and each band represents mRNAs from
five to 15 genes since the nucleotide sequences of the ORFs
are very conserved (Marzluff et al. 2002). We used radio-
labeled probes generated by PCR targeting the open reading
frame (ORF) to detect histones H2A, H2B, H3, H4, and H1
and used 7SK snRNA as a loading control (Fig. 2A).
The abundance of histone H2A, H2B, H3, and H4 mRNAs
is reduced to 37% to 70% of control levels in the SLBP
knockdown cells when compared to the C2 control. This
was a surprisingly high level, but it is consistent with
previous reports (Zhao et al. 2004) that also reported only a
relatively small reduction in core histone mRNA in HeLa
cells.
We observed a slower migrating band in the histone H4
Northern blot (Fig. 2A, panel 4), which was not present in
the control cells. We hypothesized this represented mis-
processed histone mRNA since if there were polyadenyla-
tion signals 39 of the genes, the polymerase might read
through to that site. We therefore performed both S1
nuclease protection assays and Northern blots using total
cell RNA and oligo(dT) selected total cell RNA to assess
whether there were read-through mRNAs produced in the
SLBP knockdown cells. We detected a small amount of
misprocessed histone HIST2H2AA mRNA using S1 nucle-
ase mapping (Fig. 2B), which mapped to a cryptic poly(A)
site that is utilized when an intron is inserted into this gene
(Pandey et al. 1990). There were no read-through tran-
scripts detected from the HIST2H3A gene. We used
oligo(dT) selection to confirm that the slower migrating
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histone H4 mRNA was polyadenylated (Fig. 2C). We
cloned the RNA from both the H2A and H4 histone genes,
where we observed misprocessing by oligo(dT)-primed
RT-PCR to identify (1) the particular gene that was
misprocessed and (2) the location of the polyadenylation
site. Cloning of the histone H2A band
using a pan-H2A primer targeting the
ORF revealed that this mRNA was
derived from the HIST2H2AA gene and
the polyadenylation occurred after the
HDE (Fig. 2D). The AATAAA in this
H2A gene is conserved in the mouse
and hamster (Debry and Marzluff 1994),
and the ortholog of this gene is poly-
adenylated using this canonical polya-
denylation signal in rodent testis (Moss
et al. 1994). It has been previously re-
ported that this poly(A)+ mRNA is pres-
ent when NELF1 or SLBP is knocked
down (Narita et al. 2007). We cloned
the poly(A)+ histone H4 mRNA, and
this mRNA is derived from the HIST1H4J
gene. Two different polyadenylation
sites were found both of which use a
polyadenylation signal present immedi-
ately 59 of the stem–loop sequence (Fig.
2E), which overlaps with the binding
site for SLBP. This signal is not con-
served in the mouse HIST1H4J gene.
Interestingly, the first polyadenylated
species resulted from cleavage and poly-
adenylation 5 nt 39 of the SL (21 nt
from the AAUAAA), the same site where
cleavage would occur in the presence of
SLBP. The second species of polyadeny-
lated HIST1H4J resulted from cleavage
and polyadenylation 34 nt downstream
from the AAUAAA signal, just prior to
the HDE.
Histone protein levels are reduced
in SLBP knockdown cells
Since there was still a substantial
amount of properly processed histone
mRNA in the SLBP knockdown cells for
all the core histone proteins, we sus-
pected that there must be a defect in
histone protein production other than
in histone pre-mRNA processing. Pre-
vious structure–function studies on
SLBP have shown that there is a critical
domain necessary for histone mRNA
translation (Sanchez and Marzluff 2002;
Gorgoni et al. 2005). Due to the modest
decrease in properly processed histone mRNA in SLBP
knockdown cells, we hypothesized that reduction of SLBP
might have had a more dramatic effect on histone protein
synthesis than on histone pre-mRNA processing. We
therefore investigated the levels of histone protein in SLBP
FIGURE 2. Histone mRNA levels are reduced in SLBP knockdown cells and a portion of the
mRNA is misprocessed and polyadenylated. (A) Northern blot analysis was performed on 2 mg
of total RNA from C2 and S2 treated cells. 7SK snRNA is used as a loading control. The
percentage of histone mRNA present in the S2 treated cells was quantified using Phosphor-
Imager analysis and ImageQuant software and normalizing mRNA to the 7SK snRNA levels.
These results are representative of several different experiments. Note that a slowly migrating
product reacting with the histone H4 probe (*) is present in the S2 cells. (B) 39 S1 nuclease
protection assays were used to map the 39 ends of (lanes 2,3) histone H2A (HIST2H2AA) and
(lanes 5,6) histone H3 (HIST2H3A/C) mRNAs. (Lane 3, *) The protected fragment indicates a
longer mRNA that is polyadenylated (panel D). (C) Total RNA was selected on oligo(dT)
cellulose, and equal proportions of (lanes 1,2) total RNA and (lanes 3,4) poly(A)+ RNA were
analyzed by Northern blotting for histone H4 mRNA. (*) The longer polyadenylated H4
mRNA. (D,E) Total RNA from C2 and S2 U2OS cells was primed for reverse transcription with
oligo(dT) fused to a T7 adaptor sequence and subjected to PCR using (D) a pan-H2A ORF
oligo or (E) a pan-H4 oligo together with a T7 adaptor sequence. The products were analyzed
by gel electrophoresis, the products were cloned, and multiple clones from each reaction were
sequenced. A single polyadenylation site in histone H2a was found, and two sites in the histone
HIST1H4J gene were identified.
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knockdown cells. Figure 3A demonstrates that SLBP
knockdown is >90%. We used Symplekin, a scaffold pro-
tein involved in 39-end formation (Takagaki and Manley
2000), as a loading control. Using an antibody against
histone H3, we find that total histone H3 is reduced by
z50% in the SLBP knockdown cells relative to the control
cells.
To directly test the effect of knockdown of SLBP on the
amount of histone protein, nuclear proteins were prepared
from nuclei of control cells and cells with SLBP knocked
down. The Coomassie stained gel (Fig. 3B) shows a
reduction in total protein levels for all four core histones,
consistent with the previous Western results for histone
H3. Similar results have been found in five independent
experiments, and the levels of the nonhistone proteins
remain constant. As judged by FACS analysis, the DNA
content per cell is the same in SLBP knockdown cells,
which have an increased number of cells in S-phase.
We conclude that the amount of histone protein produced
in the SLBP knockdown cells is not enough to meet
the histone protein demands of the replicating U2OS
cell, resulting in a decrease in histone protein in the SLBP
knockdown cells, and this must, at least in part,
contribute to the DNA replication and growth defects we
observed.
Regulation of histone mRNA degradation
is impaired in SLBP knockdown cells
Histone mRNA half-life is coordinately regulated with the
rate of DNA synthesis, and at the completion of S phase or
upon inhibition of DNA synthesis, there is a rapid
degradation of histone mRNA. Histone mRNA degradation
is a regulated process that requires translation of the histone
mRNA (Graves et al. 1987; Kaygun and Marzluff 2005b),
and involves the addition of an oligo(U) tail to the 39end in
order to recruit specific decay factors for rapid, bidirec-
tional decay of the mRNA (Mullen and Marzluff 2008).
Since reducing SLBP protein levels produced defects in
DNA synthesis and normal histone gene expression, we
asked if down-regulation of SLBP had an effect on histone
mRNA degradation in HeLa cells. We inhibited DNA
replication with 5 mM HU in both C2 control cells and
SLBP knockdown cells for 30 and 60 min. The represen-
tative Northern blot analysis of histone H2A mRNA
presented in Figure 3C (and graphically represented as the
average of three independent experi-
ments) reveals that the rate of histone
mRNA degradation is decreased when
SLBP protein levels are down-regulated
by siRNA. 7SK snRNA was used as a
loading control to normalize the per-
centage of histone H2A mRNA remain-
ing. Histone mRNA in the C2 control
has been significantly reduced at the 30-
min time point and is barely detectable
at the 60-min time point (Fig. 3C, lanes
2,3). In the SLBP knockdown cells,
histone mRNA degradation is stabilized
roughly 1.6-fold on average at the 30-
min time point and roughly 2.3-fold at
the 60-min time point (Fig. 3C). The
reduced rate of histone mRNA degra-
dation could reflect the inefficient
translation of histone mRNA with low
levels of SLBP and/or a requirement for
SLBP in histone mRNA degradation.
Processed histone mRNA
is retained in the nucleus
in SLBP knockdown cells
Another possibility for the low rate of
histone protein synthesis is that the
histone mRNA may be mislocalized.
We determined the subcellular localiza-
tion of the histone mRNA in SLBP
knockdown cells. As a control experiment
FIGURE 3. Histone protein levels are decreased in SLBP knockdown cells, and the normal
histone mRNA degradation in response to HU is impaired. (A) A serial dilution Western blot
analysis of C2 (1:2–1:16, lanes 1–4) and a direct comparison of (lane 5) C2 and (lane 6) S2 total
cell protein lysates. The levels of SLBP, histone H3 protein, and symplekin as a loading control
were analyzed. (B) U2OS cells were knocked down for SLBP and nuclear proteins prepared
from the control and SLBP knockdown cells. They were resolved on 15% SDS-polyacrylamide
gels and stained with Coomassie blue. (Arrows) The core histone proteins. (C) Histone H2A
mRNA is not degraded as efficiently in SLBP knockdown cells compared to control cells. HeLa
cells were treated with (lanes 1–3) C2 or (lanes 4–6) S2 siRNAs and treated with 5 mM HU,
and cells were harvested (lanes 2,5) 30 min or (lanes 3,6) 60 min later. (Left panel) Total cell
RNA was analyzed by Northern blotting with probes to H2A mRNA and 7SK snRNA as a
loading control. (Right panel) The results from three independent experiments. (Vertical bars)
Standard deviations.
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to localize histone mRNA, we synchronized HeLa cells
using double thymidine block and released them into
S phase for 3 h and performed in situ hybridization with
a probe to histone H2A. Histone H2A mRNA is localized
strongly around the nucleus in a halo-like appearance,
although some signal is present throughout the cytoplasm
(Fig. 4A, time 0). To assess probe specificity, we treated the
S-phase cells with 5 mM HU for 15, 30, or 45 min since
inhibition of DNA synthesis results in rapid degradation of
histone mRNA (Fig. 4A, 15, 30, and 45 min time points).
As expected, histone H2A signal diminished over time, and
this provided confidence that our probe specifically detects
the replication-dependent histone mRNAs.
We performed in situ hybridization to histone H2A
mRNA in HeLa and H3 mRNA in U2OS cells in which
SLBP has been knocked down. In the control HeLa cells,
histone H2A mRNA was present in the cytoplasm, with the
halo-like appearance in the perinuclear region with little to
no staining in the nucleus (Fig. 4B). In contrast, in the
SLBP knockdown HeLa cells, in situ hybridization revealed
FIGURE 4. Histone mRNA in SLBP knockdown cells is retained in the nucleus. (A) HeLa cells synchronized by double-thymidine block were
released into S phase for 3 h and treated with 5 mM hydroxyurea (HU) for 0, 15, 30, and 45 min. Cells were fixed and prepared for in situ
hybridization with antisense DIG-labeled H2a mRNA. Cells were stained with DAPI and anti-DIG antibodies, (blue) DAPI, and (red) histone
H2A mRNA. (B) Logarithmically growing HeLa cells were treated with the indicated siRNAs, and in situ hybridization was performed with
antisense DIG-labeled H3 mRNA. Note that histone mRNA accumulates in (arrows) nucleoli of HeLa cells in S2-treated cells. (C) U2OS cells were
treated with the indicated siRNAs, and in situ hybridization was performed with antisense DIG-labeled H3 mRNA as in B. Cells were stained with
DAPI. Note that there is no accumulation of histone mRNA in (arrows) nucleoli in U2OS cells. (D) U2Os cells were fractionated into nuclear and
cytoplasm and protein or (E,F) RNA from total and subcellular fractions analyzed. (Lane 1) Total, (lane 2) nuclear, and (lane 3) cytoplasmic
protein fractions were separated by 12% polyacrylamide gel electrophoresis and probed for Hsp90 (top, as a cytoplasmic marker) and fibrillarin
(bottom, as a nuclear marker by Western blotting. (E) Total (10%) input, nuclear, and cytoplasmic RNA fractions from (lanes 1–3) C2 and (lanes
4–6) S2-treated cells were separated on a 1% agarose gel, and rRNA (as a cytoplasmic marker) was visualized by ethidium bromide staining. (F)
Total, nuclear, and cytoplasmic RNAs were analyzed by Northern blot analysis, and histone H3 mRNA and U1 snRNA (nuclear marker) were
simultaneously detected using a mixture of radiolabeled probes.
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that the histone H2A mRNA was concentrated in large foci
in the nucleus, although some signal persisted in the
cytoplasm. This phenotype was rescued by expressing an
siRNA-resistant form of SLBP, SLBP* (Wagner et al. 2005)
in HeLa cells (Fig. 4B). We also performed in situ
hybridization to histone H3 mRNA in U2OS cells where
SLBP was knocked down (Fig. 4C). In U2OS cells, the
phenotype is even more dramatic than in HeLa cells (Fig.
4C). In U2OS cells, there is the characteristic halo-like
staining of histone H3 mRNA in the C2 control treated
cells, but when SLBP is knocked down (S2), the histone H3
mRNA was concentrated in the nucleus (Fig. 4C). A similar
result was also observed in SLBP knockdown U2OS cells
when in situ hybridization to histone H2A was performed
(data not shown). Since the misprocessed RNA that is
polyadenylated is presumably exported via the conven-
tional poly(A) RNA export pathway, the histone mRNA
that accumulates in the nucleus is properly processed
mRNA.
As an alternative approach to confirm the presence of
histone mRNA in the nucleus, we fractionated C2 control
and S2 knockdown cells into nuclear and cytoplasmic
fractions. We harvested protein and total RNA from these
fractions as well as from a portion of the total cell lysate.
Hsp90 and fibrillarin were used as cytoplasmic and nuclear
markers, respectively, and they were present almost exclu-
sively in the appropriate fraction (Fig. 4D). The first lanes
in Fig. 4D represent 100% of the total input from unfractio-
nated cells. Similarly, the ribosomal RNA was largely in the
cytoplasmic fraction (Fig. 4E, lanes 2,3).
We also analyzed the histone mRNA in each of the
subcellular fractions from the same experiment, and simul-
taneously probed for histone H3 mRNA and U1 snRNA as
a control (Fig. 4F). Consistent with the nuclear localization
of spliceosomal snRNAs, we observed that U1 was concen-
trated in the nuclear fraction of both the C2 control and S2
knockdown (Fig. 4F, lanes 2,5). A small amount of U1
snRNA was detected in the cytoplasm (Fig. 4F, lanes 3,6).
Histone H3 mRNA was concentrated in the cytoplasm of
C2 control cells (Fig. 4F, lane 3), but in the SLBP
knockdown cells, z50% of the histone mRNA was in the
nucleus. Since the nuclear volume is z10% of the volume
of the cytoplasm (S2) (Fig. 4F, cf. lanes 3 and 6), this result
is consistent with the high concentration of histone mRNA
in the nucleus detected by in situ hybridization. Sequestra-
tion of histone mRNA in the nucleus upon loss of SLBP is
consistent with the decrease in histone protein synthesis
due to decreased translation, as well as the failure to rapidly
degrade histone mRNA when DNA replication was
inhibited.
Taken together these results demonstrate that the major
lesion in histone mRNA metabolism when SLBP is knocked
down more than 95% is in export of the histone mRNA to
the cytoplasm. Processed histone mRNA accumulates in
the nucleus, and is relatively stable. Thus the primary
molecular defect in histone mRNA metabolism when SLBP
is knocked down to 2%–5% of normal levels is the retention
of processed histone mRNA in the nucleus.
Tethering of SLBP to nonspecific mRNA results
in nuclear export
Many general mRNA export factors, including TAP and
Rev, promote export to the cytoplasm when tethered to
nonspecific mRNAs (Yi et al. 2002). To determine if SLBP
facilitates nuclear export of mRNA, we utilized a well-
characterized CAT (chloramphenicol acetyl transferase)
reporter system. The pDM128/PL reporter contains a
CMV-driven bacterial CAT gene located within an intron
derived from HIV-1. Under standard conditions, the CAT
mRNA is spliced out of the reporter and not expressed
due to its nuclear retention. Robust CAT activity can be
achieved by the insertion of four MS2 binding sites adjacent
to the CAT gene coupled with the expression of a heterol-
ogous fusion protein containing the MS2 coat protein and
a factor capable of mRNA export (i.e., TAP). The activity
results from the export of the CAT mRNA prior to it get-
ting spliced out of the reporter. 293T cells were cotrans-
fected with either pDM128/PL or pDM128/PL-4XMS2 and
HA-MS2 fused to TAP, Rev, or SLBP. Expression of MS2-
TAP and MS2-Rev resulted in increased levels of CAT
activity from the pDM128/PL-4XMS2 reporter compared
to the reporter lacking MS2 sites (Fig. 5A), as has been
reported for other transport factors (Yang et al. 2001;
Wiegand et al. 2002). Cotransfection of MS2-SLBP with the
MS2 reporter results in CAT activity levels z50% of those
observed for TAP and Rev, while coexpression of HA-MS2
had no effect on either reporter. Levels of MS2-TAP, MS2-
SLBP, MS2-Rev, and HA-MS2 were determined by Western
blotting (Fig. 5B). Note that levels of MS2-TAP expression
were lower as reported previously (Wiegand et al. 2002).
These data indicate that tethering SLBP to a nonspecific
mRNA is sufficient to promote nuclear export, albeit not as
efficiently as TAP or Rev.
DISCUSSION
As the only mRNAs that are not polyadenylated, metazoan
histone mRNAs require a distinct set of factors for pre-
mRNA processing, translation, and regulation of stability.
A common factor in all these processes is SLBP, which
binds the stem–loop in the histone pre-mRNA during
transcription, remains associated with the mRNA during
translation, and is involved in histone mRNA degradation
(Marzluff et al. 2008). Here we have ascertained the effect
of knocking down SLBP in mammalian cells to <5% of the
normal level. The cells remain viable and continue growing
at a slow rate. Surprisingly, there is only a modest effect on
the accumulation of processed histone mRNA, but a
substantial fraction of the histone mRNA is retained in
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the nucleus, suggesting a previously unrecognized role of
SLBP in histone mRNA export in vivo.
We, and others, have previously shown that knocking
down SLBP results in slow growth of cells and an
accumulation of cells in S-phase (Zhao et al. 2004; Wagner
et al. 2005). This effect is due to the SLBP knockdown since
normal growth can be restored by expression of an RNAi-
resistant SLBP (Wagner et al. 2005). Progression through S-
phase was slowed as judged by the release of cells from
either nocodazole or HU blocks (Zhao et al. 2004). This is
in contrast to knocking down components of the U7
snRNP, which result in an arrest of cells in mid-G1
(Wagner and Marzluff 2006). This evidence suggests that
the cell monitors the ability to synthesize histone mRNA by
monitoring the presence of an active U7 snRNP, but that
cells enter S phase normally when SLBP is reduced.
SLBP is a relatively unstable protein, being degraded at
the end of S-phase and not accumulating again until just
prior to entry into the next S-phase (Whitfield et al. 2000;
Zheng et al. 2003). Thus, it is relatively easy to obtain
effective knockdown of the SLBP protein, although for the
phenotypes observed here SLBP must be knocked down
>95%, and with long exposures of the Western blots, we
detect small amounts of SLBP in the knockdown cells.
Thus, the results reported here reflect the phenotypes
observed when SLBP is severely limiting but not absent
from cells.
The most obvious effect of knocking down SLBP is a
slow growth rate and a change in cell cycle distribution of
the cells, with an accumulation of cells in S-phase. The cells
continue dividing, and we see no evidence of apoptosis
during the five to six day course of the experiments. The
accumulation of cells in S-phase is due to a slower pro-
gression through S phase as a result of a reduced rate of DNA
replication (Fig. 1). We suggest that the
reduced rate of replication is due to a
failure to provide replication-dependent
canonical histones to the chromatin
assembly machinery at a sufficient rate.
This likely results in defects at the
replication fork, leading to activation
of the S-phase checkpoint and slowing
the rate of DNA replication. Similar
phenotypes have been observed with
knockdown of CAF1, the major chro-
matin assembly factor for the canonical
but not the replication-independent
histones (Ye et al. 2003).
Surprisingly, the overall level of his-
tone mRNAs is only reduced about
twofold in SLBP knockdown cells, and
the great majority of the histone mRNA
is accurately processed. This implies
that the residual SLBP in the cell must
be preferentially used for histone pre-
mRNA processing. One possibility is that the residual SLBP
might be concentrated in the Cajal body, where it could
function in histone pre-mRNA processing, but we were not
able to detect a specific localization by immunofluores-
cence. There is a small amount of misprocessed polyade-
nylated mRNA that accumulates from some of the histone
genes, suggesting that the efficiency of processing is reduced
in the SLBP knockdown mutants. The HIST2H2AA gene
has been previously shown to have a cryptic polyadenyla-
tion site in the HDE that is used when histone processing is
disrupted by insertion of an intron (Pandey et al. 1994),
and in round spermatids (Moss et al. 1994). This mRNA is
also polyadenylated when NELF, a transcription elongation
inhibitor, is knocked down (Narita et al. 2007). There is
also a polyadenylated histone H4 mRNA that accumulates
when SLBP is knocked down. This mRNA is derived from a
single histone H4 gene, HIST1H4J, which contains a
polyadenylation signal in the 39-UTR, just before the
stem–loop. Although the position of the poly(A) tail is at
the same site as the cleavage site for histone mRNA, it is
likely that this polyadenylation signal, which overlaps the
SLBP binding site, directs the cleavage of the HIST1H4J
pre-mRNA to yield the polyadenylated mRNA. Each of
these polyadenylation signals overlaps a cis-element
required for histone mRNA processing, suggesting that
normally the histone processing machinery preferentially
associates with these signals.
Unlike the situation in Drosophila (Lanzotti et al. 2002;
Godfrey et al. 2006), there is not extensive read-through of
histone transcripts resulting in polyadenylated mRNAs in
mammalian cells when SLBP is reduced. This may reflect a
need in Drosophila for efficient termination between closely
spaced histone genes, or there may in fact be a role for
polyadenylated histone mRNAs in particular cell types
FIGURE 5. SLBP promotes mRNA export. (A) 293T cells were transfected with 25 ng of
reporter plasmid and 500 ng of HA-MS2 fusion protein plasmid. Forty-eight hours post-
transfection, cells were harvested in TEN buffer and a CAT assay was performed on the lysates.
CAT activity was normalized to untransfected lysates. Values are for three independent
experiments with error bars representing 1 standard deviation. (B) The cell lysates from cells
transfected with the two reporters were analyzed by Western blotting using antibody against
the HA tag, except for SLBP where the anti-SLBP antibody was used.
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during development. The role of SLBP in the processing of
histone pre-mRNA is ‘‘catalytic,’’ allowing cells to perform
this function even under limiting concentration of SLBP,
and then SLBP can be released for processing more histone
mRNAs. However the requirement for SLBP in other steps
in histone mRNA metabolism (e.g., export or translation)
is likely stoichiometric, and the RNAi-mediated reduction
in SLBP levels therefore interferes with these functions.
Transport of histone mRNA
Most mRNAs are transported through a pathway that
requires TAP (yeast mex67p) as an adaptor protein for
export (Erkmann and Kutay 2004). TAP can be recruited to
mRNAs derived from spliced pre-mRNAs by binding to
components of the exon–junction complex deposited near
the exon–exon border after splicing. Unspliced mRNAs
such as histone mRNAs must recruit TAP by a different
mechanism. There have been several studies relevant to
histone mRNA export from the nucleus. In one study the
role of processing was assessed by forming the histone 39
end either by a normal processing reaction or by ribozyme
cleavage (Eckner et al. 1991). They found that mature
histone mRNAs were cytoplasmic regardless of the mech-
anism of 39 end formation. However, if the histone ORF
was replaced with the chloramphenicol acetyl transferase
ORF, then the mRNA formed by the processing reaction
was cytoplasmic, and the mRNA formed by the ribozyme
was retained in the nucleus.
Huang and Steitz (2001) studied elements in the histone
ORF that were capable of directing transport of an heter-
ologous mRNA in Xenopus oocytes and identified a binding
site for the SR protein 9G8 responsible for this activity. The
binding site is contained within a region of the histone ORF
capable of conferring cytoplasmic localization on other
unspliced mRNAs (Huang and Carmichael 1997). These
studies suggest a role for 9G8 protein in recruiting TAP and
provide a partial explanation for the observed conservation
in the nucleotide sequence level in histone ORFs at that site
(Debry and Marzluff 1994; Friend et al. 2007). In a previous
study of histone mRNA export in Xenopus oocytes, we
found there was not a requirement for any specific
nucleotide sequence, including the 39 end of histone mRNA
or SLBP, for histone mRNA export (Erkmann et al. 2005a)
in Xenopus oocytes. This study suggested there are multiple
potential binding sites for proteins that could recruit TAP
and that in Xenopus oocytes there is a large supply of these
proteins, which is in agreement with other studies that
showed the length of the RNA was a major determinant of
its transport efficiency in Xenopus oocytes (Masuyama et al.
2004).
In mammalian cells with active RNA metabolism, there
is likely to be competition among the mRNAs for the
binding proteins and export factors, just as there is for
factors involved in RNA processing. Thus it is not surpris-
ing to find there might be more stringent requirements for
export in mammalian cells than in Xenopus oocytes. Our
results suggest there is a critical role for SLBP in histone
mRNA export in mammalian cells.
Overall, these results are consistent with a model wherein
multiple factors may need to bind to a RNA for efficient
export. The processing reaction may facilitate recruitment
of some of these factors (Eckner et al. 1991), and there are
clearly sequence elements in the histone ORF that promote
export (Huang and Carmichael 1997; Huang and Steitz
2001) of mRNAs. Our results suggests that association of
SLBP is necessary to promote efficient transport of histone
mRNA but not to stabilize the histone mRNA in the
nucleus.
When SLBP levels are greatly reduced, mature histone
mRNAs accumulate in the nucleus. A striking aspect of
this result is that these mRNAs accumulate to substantial
levels. When mutations are introduced into the histone
stem–loop that alter SLBP binding (Pandey et al. 1994) or
the HDE is deleted preventing U7 snRNP binding (Chodchoy
et al. 1991), or when the HDE is naturally suboptimal (Liu
et al. 1989), then the unprocessed mRNAs do not accu-
mulate, but rather, must be rapidly degraded. The same is
true of improperly processed mRNAs from polyadenylated
transcripts. In the SLBP knockdown cells, histone mRNAs
are properly processed, and direct sequencing of the
mRNAs after circular RT-PCR (Mullen and Marzluff
2008) did not reveal any alterations at the 39-end of
the mRNA (E.J. Wagner, unpubl.). Thus these mature
mRNAs, which are not bound to SLBP, are still stable in
the nucleus. They may be stable in the nucleus since they
have gone through the normal processing pathway, despite
the fact that they cannot be exported. A model for
histone mRNA export in normal cells and for the nuclear
retention of histone mRNA in SLBP knockdown cells is
shown in Figure 6.
Decreased levels of histone protein
in SLBP knockdown cells
The second feature of the SLBP knockdown cells is that
they have a lower amount of histone protein, consistent
with a defect in histone protein biosynthesis. Initially we
found this surprising, since one might think that reducing
histone protein:DNA ratios twofold might have a profound
effect on cell physiology and viability. However, in at least
one situation, infection of human T lymphocytes with
HTLV1, there is an approximately twofold reduction in
histone:DNA ratios and mediated by a reduction in core
histone mRNA expression without affecting DNA replica-
tion (Bogenberger and Laybourn 2008). In yeast one can
vary the histone:DNA ratio by changing the dosage of the
histone genes (Gunjan and Verreault 2003) or in some
mutants by chromatin modification (Xiao et al. 2007; B.D.
Strahl, pers. comm.) without affecting viability.
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Conclusions
SLBP is essential for the proper accumulation of histones
for assembly of newly replicated DNA into chromatin. Our
results suggest that a major consequence of SLBP depletion
is the failure to export properly processed histone mRNA.
This suggests that SLBP must be associated with histone
mRNA for export and that SLBP may dissociate from
histone mRNA after processing and additional nucleoplas-
mic SLBP may then reassociate with the histone mRNA
prior to export. Understanding and identifying the com-
ponents of the nuclear histone mRNP, as well as the
cytoplasmic histone mRNP, will help elucidate the pathway
between processing of the mRNA at the site of transcription




RNAi was performed using a two-hit method as previously
described using Lipofectamine 2000 (Wagner and Garcia-Blanco
2002). Briefly, 110,000 U2OS or 95,000 HeLa cells were plated into
24-well plates, and the following day, siRNAs were transfected
into cells. A day following the first hit of siRNA, cells were
replated into six well dishes, allowed to grow an additional day,
and then transfected with the second hit of siRNA. Cells were
harvested 48–72 h following the second hit for analysis. The
siRNA sequences of the C2 (control) and S2 (SLBP) have been
previously described (Wagner et al. 2005).
DNA synthesis and mitotic index measurements
by FACS
We quantified the percentage of bromodeoxyuridine (BrdU)
labeled cells in S phase and phospho-histone H3 in mitosis as
previously described (Doherty et al. 2003). As controls for these
assays, cells were treated with 5 mM HU for 1 h prior to addition of
the BrdU. To measure DNA synthesis in S phase, RNAi-treated cells
were pulsed with a 1 mM stock solution of BrdU (10 mM final
concentration) for 1 h. Acid-treated nuclei were resuspended with
100 mL of a solution containing a-BrdU antibody conjugated to
FITC (Becton Dickinson) diluted 1:5 in IFA (10 mM HEPES at pH
7.4, 150 mM NaCl, 4% FBS, 0.1% NaN3) plus 0.5% Tween-20 and
incubated in the dark for 2 h at room temperature. Following the
incubation, 2 mL of IFA plus 0.5% Tween-20 was added, and nuclei
were recovered by centrifugation. Nuclei were resuspended in 500
mL of the IFA plus 0.5% Tween solution containing 5 mg/mL
RNase A and 50 mg/mL propidium iodide. Nuclei were incubated
overnight at 4°C and analyzed on a Becton-Dickinson (Becton
Dickinson) FACScan using Summit Software (Dako Cytomation).
To measure the mitotic index using phospho-histone H3 as a
marker, cells were fixed with 1% formaldehyde in PBS for 30 min.
Fixed cells were pelleted at 1200 rpm for 5 min at 4°C and the
supernatant removed. Cells were resuspended in 1.5 mL of PBS,
and then 3 mL of cold 100% ethanol was added and cells were
stored overnight at 4°C. The cells were resuspended in 100 mL of a
solution containing 0.5 mg of phospho-histone H3 (serine 10)
antibody (Upstate Biotechnology) and 5 mg/mL RNase A in IFA
plus 0.5% Tween-20 for 2 h at room temperature. The cell pellet
was resuspended in 100 mL of the IFA plus 0.5% Tween-20
solution containing an anti-rabbit secondary antibody conjugated
to FITC (Santa Cruz Biotechnology) for 1 h at room temperature.
The cells were resuspended in 500 mL of the IFA plus 0.5% Tween
solution containing 5 mg/mL RNase A and 50 mg/mL propidium
iodide and analyzed by FACS.
Northern blot analysis and S1 nuclease
protection assays
Northern blot analysis to replication-dependent histone genes and
7SK snRNA was performed as described previously (Mullen and
Marzluff 2008). Briefly, 2 mg of total RNA was resolved on 6%
urea–polyacrylamide gels, transferred to Hybond N+ nitrocellu-
lose (Amersham Biosciences), and probed in QuickHyb (Strata-
gene) overnight at 60°C. Probes were generated by random
FIGURE 6. Model of SLBP-dependent histone mRNA export. (A)
Histone mRNA metabolism in normal S-phase cells. SLBP remains
associated with the histone mRNA in the nucleus, and the mRNA is
efficiently exported associated with multiple proteins that recruit
TAP. (B) Histone mRNA metabolism in cells depleted of SLBP.
Histone mRNA is processed normally by the residual SLBP, but that
SLBP dissociates from the processed mRNA before it can be exported,
and the processed message remains in the nucleus, where it is stable.
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primed, a32P-dCTP labeling (PrimeIt II Kit; Stratagene) of PCR
products generated to the complete ORF of cloned human histone
genes and to 7SK RNA (Mullen and Marzluff 2008).
S1 nuclease protection assays to map the 39 ends of histone H2a
(HIST2H2AA) and H3 (HIST2H3A/C) were performed as pre-
viously described (Kaygun and Marzluff 2005a). Probes for 39-end
labeling were generated by digestion of the HIST2H2AA gene with
AscI and the HISTH3A/C gene with BssHI. The digested plasmid
DNA was 39-end labeled with a32P-dCTP and Klenow (New
England BioLabs) and hybridized with total cell RNA. Protected
fragments were resolved on 6% urea–polyacrylamide gels.
Western blot analysis
Protein lysates from RNAi-treated cells were prepared as pre-
viously described (Mullen and Marzluff 2008) and the concen-
trations quantified using Bradford reagent. The primary
antibodies used in this study include rabbit anti-SLBP (Wang
et al. 1996), mouse anti-symplekin (BD Biosciences), rabbit anti-
fibrillarin (Abcam), rabbit anti-Hsp90 (Cell Signaling Technol-
ogy), and rabbit anti-histone H3 (Abcam). Protein were resolved
on 12% SDS–polyacrylamide gels and transferred to nitrocellulose
before detection using appropriate primary and secondary anti-
bodies.
In situ hybridization
In situ hybridizations were performed as described (Erkmann
et al. 2005a). RNAi-treated cells were grown on coverslips and
washed with PBS and fixed in 3.7% PFA in PBS for 10 min at
room temperature. Cells were then washed again and permeabi-
lized in 0.5% Triton X-100 in PBS. Pre-hybridization was
performed for 10 min at 37°C using a solution of 43 SSC and
50% formamide preheated to 37°C. Coverslips were inverted onto
a 5–10-mL drop of hybridization solution (50% deionized
formamide, 10% dextran sulfate, 13 Denhardt’s solution, 43
SSC, 1 mg/mL Escherichia coli tRNA) containing 1 ng/mL DIG
labeled H2A or H3 probe. Probes were denatured for 5 min at
80°C and cooled on ice prior to addition to hybridization
solution. Hybridizations were performed overnight at 37°C in a
humidified chamber. Cells were washed once with 23 SSC at
37°C, 33 in 60% formamide in 0.23 SSC at 37°C, once in 23
SSC at room temperature, and 33 with 0.5% Tween-20 in 43
SSC. Coverslips were inverted onto 8-mL drops of 0.5% Tween-20
in 43 SSC containing mouse Cy3 a-DIG antibody diluted 1:200
and incubated for 1 h at 37°C in a humidified chamber. Coverslips
were washed three times with 0.5% Tween-20 in 43 SSC and
inverted onto 8-mL drops of 0.5% Tween-20 in 43 SSC contain-
ing Cy-3 a-mouse secondary antibody diluted 1:200. Secondary
incubation was performed for 45 min at 37°C in a humidified
chamber. Coverslips were washed 33 with 0.5% Tween-20 in 43
SSC before being fixed with 3.7% PFAin PBS for 5 min at room
temperature. After a PBS wash, coverslips were DAPI-stained and
mounted onto slides using Fluorsave reagent (Calbiochem).
Images were acquired using a Zeiss LSM 510 confocal microscope
and analyzed using ImageJ software.
CAT assay
CAT assays were performed essentially as described (Cullen 2004).
293T cells (3 3 105) were cotransfected with 25 ng of reporter
plasmid and 500 ng of MS2-fusion plasmid using Lipofectamine-
2000. Forty-eight hours after transfection, cells were harvested in
TEN buffer (100 mM NaCl, 10 mM EDTA, 10 mM Tris-HCl at
pH 7.5), pelleted, and resuspended in 100 mL of 100 mM Tris-HCl
(pH7.5). Cells were lysed by freeze–thawing three times, and
lysates were pelleted for 5 min at 4°C. Equal amounts of lysates
were added to 300 mL of CAT assay buffer (5 mg/mL chlor-
ampenicol in 100 mM Tris-HCl at pH 7.5 containing 1 mL/mL
[3H]acetyl coenzyme A). Three milliliters of Econofluor (Packard)
scintillation cocktail was added to each sample, and counts were
determined in a scintillation counter.
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